Exelon Corporation$45.49ED · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $17.05B | $15.47B | $14.48B | $15.46B | $13.46B | $12.03B | $12.14B | $11.93B |
| Research & Development | — | — | — | $27.00M | $25.00M | $24.00M | $24.00M | $24.00M |
| Operating Expenses | $13.99B | $12.52B | $12.33B | $13.05B | $10.85B | $9.59B | $9.90B | $9.80B |
| Operating Income | $2.94B | $2.67B | $3.20B | $2.62B | $2.83B | $2.65B | $2.68B | $2.66B |
| Interest Expense | $1.23B | $1.19B | $1.02B | $852.00M | $905.00M | $1.02B | $991.00M | $819.00M |
| Other Income / (Expense) | $895.00M | $655.00M | $830.00M | $326.00M | -$538.00M | -$401.00M | $51.00M | -$62.00M |
| Income Before Taxes | $2.60B | $2.14B | $3.00B | $2.10B | $1.38B | $1.23B | $1.74B | $1.78B |
| Provision for Income Taxes | $574.00M | $318.00M | $487.00M | $498.00M | $190.00M | $90.00M | $296.00M | $401.00M |
| Net Income | $2.02M | $1.82M | $2.52M | $1.66M | $1.35M | $1.10B | $1.34B | $1.38B |
| Basic EPS | $5.66 | $5.26 | $7.25 | $4.68 | $3.86 | $3.29 | $4.09 | $4.43 |
| Diluted EPS | $5.64 | $5.24 | $7.21 | $4.66 | $3.85 | $3.28 | $4.08 | $4.42 |
| Basic Shares Outstanding | 357.40M | 346.00M | 347.70M | 354.50M | 348.40M | 334.80M | 328.50M | 311.70M |
| Diluted Shares Outstanding | 358.70M | 347.30M | 349.30M | 355.80M | 349.40M | 335.70M | 329.50M | 312.90M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $6.09 | $6.00 | $6.15 | 9 | ↑1 ↓1 |
| Dec 2027 | $6.43 | $6.00 | $6.55 | 10 | ↑2 ↓1 |
| Dec 2028 | $6.90 | $6.87 | $6.94 | 5 | ↑2 ↓0 |
| Dec 2029 | $7.41 | $7.32 | $7.49 | 2 | ↑1 ↓0 |
